Role of pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the management of neonatal sepsis.

Objective: To investigate the effectivity of pentoxifylline (PTX) and immunoglobulin M (IgM)-enriched intravenous immunoglobulin (IVIG) therapy in the treatment of neonatal sepsis (NS), alone or in combination.

Study Design: This was a prospective, double-blind, controlled study. Newborns with suspicion of sepsis were enrolled in the study.